المؤلفون: Kenneth W. Mahaffey, John H. Alexander, Karen P. Alexander, Matthew T. Roe, Kathleen M. Trollinger, Patrícia O. Guimarães, Claes Held, Chiara Melloni, Ghazala Haque, Stefan James, Erik Magnus Ohman, André Zimerman, Pierluigi Tricoci, Renato D. Lopes, Brian Tinga, Karen S. Pieper, Amanda Stebbins

المصدر: American Heart Journal. 174:60-67

مصطلحات موضوعية: Male, Canada, medicine.medical_specialty, Acute coronary syndrome, Myocardial Infarction, 030204 cardiovascular system & hematology, Risk Assessment, law.invention, Electrocardiography, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Internal medicine, Myocardial Revascularization, medicine, Humans, 030212 general & internal medicine, Acute Coronary Syndrome, Intensive care medicine, Adverse effect, Aged, Retrospective Studies, business.industry, Proportional hazards model, Incidence, Incidence (epidemiology), Hazard ratio, Anticoagulants, Middle Aged, Prognosis, medicine.disease, Patient Discharge, United States, Europe, Survival Rate, Clinical trial, Platelet aggregation inhibitor, Female, Cardiology and Cardiovascular Medicine, business, Platelet Aggregation Inhibitors, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7419fc6175849470fbcbec02e915a79
https://doi.org/10.1016/j.ahj.2016.01.003